MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Association of expanded CAG repeat with autonomic function in Spinocerebellar Ataxia Type-2 (SCA-2)

A. Sonakar, F. Faruq, A. Srivastava (NEW DELHI, India)

Meeting: 2024 International Congress

Abstract Number: 1298

Keywords: Ataxia: Clinical features, Autonomic dysfunction, Spinocerebellar ataxias(SCA)

Category: Ataxia

Objective: To investigate association of expanded CAG repeat with autonomic function in SCA2 patients.

Background: SCA2 is a progressive neurodegenerative disorder characterized by gait, limb ataxia and autonomic dysfunction. It is an autosomal dominant disease caused due to expansion of trinucleotide CAG repeats in ATXN2.

Method: A total 137 SCA2 individuals with genetic confirmation were gathered from AIIMS’s Ataxia Clinic. Every patient had a thorough clinical assessment as well as tests for biochemistry, electrophysiology, and radiography. A thorough evaluation of their autonomic function was conducted, which included the following tests: a) deep breathing; b) Valsalva maneuver; c) isometric exercise; d) cold pressor test; and e) postural assessments. If any of the aforementioned testing domains showed abnormalities, autonomic function was deemed abnormal. Their genetic spectrum and autonomic functioning were connected.

Results: Total 137 unrelated SCA2 patients (47 Male and 90 females) had mean (SD) expanded trinucleotide repeats of 41.86(+4.24) with a range of 36-54. Autonomic function parameters were abnormal in 86 (62.77%) with expanded CAG range of 33-54 repeat and normal 51(37.22%) with expanded CAG range 36-48 repeats. In patients with normal Autonomic function, mean (SD), range of age at onset was 28.02(10.86), 16-44 and mean (SD), of CAG repeat is 41.64(3.57). In patients with abnormal Autonomic function, mean (SD), range of age at onset is 34.75 (8.65), 12-52 and mean (SD), of CAG repeat is 40.34(2.50). No significance difference has been observed in these two group.

Conclusion: SCA2, the most prevalent spinocerebellar ataxia in India shows great clinico-genetic heterogeneity. Our study shows that number of Trinucleotide repeats (TNR) may not be causal for abnormal autonomic function in SCA2 patients.

To cite this abstract in AMA style:

A. Sonakar, F. Faruq, A. Srivastava. Association of expanded CAG repeat with autonomic function in Spinocerebellar Ataxia Type-2 (SCA-2) [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/association-of-expanded-cag-repeat-with-autonomic-function-in-spinocerebellar-ataxia-type-2-sca-2/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/association-of-expanded-cag-repeat-with-autonomic-function-in-spinocerebellar-ataxia-type-2-sca-2/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley